Our Nine Research Priorities
The AGITG research priorities and strategic activities drive our efforts to accelerate the pace of discovery and connect researchers working across institutions and disciplines. The challenges of treating gastro-intestinal (GI) cancers are vast and the impact that these diseases have is devastating.
Set by the Scientific Advisory Committee, the priorities look to identify the areas of greatest need and ideas that have the potential to significantly improve the knowledge base for clinical decision-making.
The research priorities are reviewed annually with input from the AGITG membership. Over time, they will evolve with the cancer research landscape and to reflect advancing science and unmet clinical needs.
We are currently addressing our research priorities in the following ways:
- Expanding access to clinical trials in remote, regional and rural areas by incorporating Tele-Trial sites where feasible.
- Engaging with members and industry to discuss research opportunities in hepatocellular carcinoma.
- Endorsed trials focused on liver cancer: SOCRATES and ICEMELT.
- Development of embryonic ideas in rectal cancer with a focus on neoadjuvant treatment through the Idea Generation Workshop, in collaboration with TROG Cancer Research.
- Implementing patient reported outcomes and translational research endpoints from concept development.
- Explore new collaboration opportunities with cancer trial groups in Ireland and Brazil.